The Birmingham Epidermolysis Bullosa Severity (BEBS) score of EB patients
$ 21.00 · 4.9 (739) · In stock
Angel Is 2016
Clinical and molecular studies in two patients with dystrophic epidermolysis bullosa - Indian Journal of Dermatology, Venereology and Leprology
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB) - ScienceDirect
EB Kids Study Links Low Vitamin D, Severe Disease to Poor Bone Health
PDF) Homocysteine metabolism in children and adolescents with epidermolysis bullosa
The Birmingham Epidermolysis Bullosa Severity (BEBS) score of EB patients
Epidermolysis bullosa (EB) Short Form-36 scores compared to gender- and
The Birmingham Epidermolysis Bullosa Severity (BEBS) score of EB patients
Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study, Orphanet Journal of Rare Diseases
Epidermolysis Bullosa
Epidermolysis bullosa: recognition and management - The Pharmaceutical Journal
Birmingham epidermolysis severity score and vitamin D status are associated with low BMD in children with epidermolysis bullosa
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB). - Abstract
A single-centre study on predictors and determinants of pubertal delay and growth impairment in Epidermolysis Bullosa
Clinics and Practice, Free Full-Text